Genomics, Vertex extend drug discovery alliance in $220m deal
The renewed collaboration focuses on applying human genetics to discover and validate new drug targets for precision medicines.
The renewed collaboration focuses on applying human genetics to discover and validate new drug targets for precision medicines.